The global hesperidin market is estimated to create an incremental opportunity of more than US$ 200 Mn by the end of 2022, exhibiting growth at a robust CAGR of nearly 7% to 8% during the forecast period 2022-2032. The sales of hesperidin are estimated to surpass a valuation of US$ 400 Mn by 2032, in comparison to the US$ 185 Mn registered in the year 2021.
| Report Attribute | Details |
| Hesperidin Market Registered Base Value (2021) | US$ 185 Million |
| Hesperidin Market Expected Value (2022) | US$ 200 Million |
| Hesperidin Market Anticipated Value (2032) | US$ 400 Million |
| Hesperidin Market Projected Growth Rate (2022-2032) | 7% to 8% CAGR |
Hesperidin is a plant chemical classified as a bioflavonoid that is present in citrus fruits such as lemons, sweet limes, oranges grapefruits, and others. It is flavanone glycoside extracted from the peels of citrus fruits using various processes. It is used as a flavoring and sweetening agent to enhance the taste of a wide variety of beverages and food preparations.
Hesperidin is garnering huge popularity across the pharmaceutical and dietary supplement industry, owing to its ability to increase the bioavailability of vitamin C, boost immune system, and protect against infectious & inflammatory diseases. It also possesses anti-inflammatory anti-bacterial properties and anti-oxidant properties.
Attributed to these properties, it is finding a wide range of applications across various industries such as food & beverage, personal care & cosmetics, and others for the production of beverages, juices, face creams, body lotions, serums, and others. Hence, growing demand for these products is projected to create lucrative growth opportunities in the global hesperidin market.
Growing awareness regarding the side effects associated with the consumption of hesperidin such as contact dermatitis, abdominal pain, nausea, and diarrhea among others is hindering the growth in the global market.
Also, lack of awareness about the health benefits of hesperidin among consumers and increasing availability of low cost dietary supplements such as minerals, multivitamins, and others in the market is restraining the sales of hesperidin in the market.
As per a study by FMI, North America is projected to account for the lion’s share in the global hesperidin market during the forecast period 2022-2032.
Over the past couple of years, there is a swift rise in burden of blood vessel conditions such as hemorrhoids, varicose veins, and others across North America, creating strong demand for associated drugs and supplements.
For instance, according to the National Institute of Diabetes and Digestive and Kidney Diseases, around half of the population above the age of 50 or 1 in 20 people in the U.S. is reported to be suffering from hemorrhoids. As hesperidin is either used in combination with other citrus bioflavonoids or alone for the treatment of hemorrhoids and others blood vessel conditions, growing prevalence of such disorders is estimated to bolster the demand in the North America market.
East Asia is expected to emerge as a highly remunerative market for hesperidin in the global market from 2022 to 2032, reveals Future Market Insights.
Due to the growing awareness regarding lifestyle diseases, a significant rise in health and fitness trends is being witnessed across East Asia, fueling the demand for dietary supplements. Hesperidin assists in maintaining the integrity of the vascular system and promoting healthy blood circulation to help maintain good heart health. Hence, rising demand for dietary supplements is bolstering the sales in the market.
In addition to this, hesperidin increasing being used in the production of all natural an- plant based products of body lotion, serums, and other, owing to its high antioxidant properties and refreshing citrus fragrance. Hence, rising customer inclination towards plant-based personal care & cosmetics products is anticipated to favor the growth in the East Asia market.
Some of the leading players in the hesperidin market are Merck KGaA, Central Drug House (P) Ltd., AuNutra Industries Inc., Thermo Fisher Scientific Inc., Santa Cruz Biotechnology, Inc., Cayman Chemical Company, Inc., HiMedia Laboratories Pvt. Ltd., J&K Scientific Ltd., Tokyo Chemical Industry Co., Ltd., Henan Tianfu Chemical Co., Ltd., others.
Prominent players in the global hesperidin market are aiming at production capacity expanding and merger & acquisition to increasing their share in the highly competitive market.
| Report Attribute | Details |
| Growth Rate | CAGR of 7% to 8% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Million, Volume in Kilotons and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Countries Covered |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
By Source:
By Grade:
By End Use:
By Region:
FMI projects the sales of hesperidin in the market is expected to rise at 7% to 8% value CAGR by 2032
The global hesperidin market is anticipated to be dominated by North America over the forecast period 2022-2032.
Merck KGaA, Central Drug House (P) Ltd., AuNutra Industries Inc., Thermo Fisher Scientific Inc., Santa Cruz Biotechnology, Inc., Cayman Chemical Company, Inc., HiMedia Laboratories Pvt. Ltd., J&K Scientific Ltd., Tokyo Chemical Industry Co., Ltd., Henan Tianfu Chemical Co., Ltd., among others some of the leading players in the global hesperidin market.
Explore Similar Insights
Hesperidin Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
